Christopher Taron

Chris is Head of the Gene Expression Division at New England Biolabs (NEB), a world leader in recombinant enzyme production. He received his PhD from the University of Illinois, Urbana and was a Co-founder and Director at BioDisplay Technologies Inc., prior to its acquisition by Abbott Laboratories. He played a leading role in the commercial development of the K. lactis yeast-based protein expression platform sold in NEB’s catalog and used for internal manufacturing. As head of NEB’s Gene Expression Division, he oversees the development of novel technologies that improve protein production in microbes. Additionally, his research lab is focused on glycobiology with an interest in the biosynthesis of various types of protein glycosylation.